The U.S. Food and Drug Administration (FDA) is continuing to review data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus (esophageal cancer).
Osteoporosis, a common bone disease, affects women about 80 percent of the time. This often leads to the mistaken assumption that men aren’t affected by the disease.
